IMARC has a long relationship with Kuno Creative, dating back to its rebranding and development of a new website nearly a decade ago.
IMARC’s team members had extensive knowledge they were eager to share, but they were so busy in the field that they didn’t always have time to consistently publish whitepapers, blogs and other resources. They needed a marketing partner who understood the complexities of their industry and could guide them in content creation and distribution while allowing their team’s expertise to shine through, making the process as efficient as possible.
Kuno helped IMARC build a vast library of digital resources over several years.
The company became known as a leading voice in the clinical research industry.
Once IMARC had established authority, the leadership team worked with Kuno to set more specific goals that aligned with its business development efforts.
Content Marketing Efforts
In the past year, IMARC identified four key initiatives they wanted to promote that could help them close more deals. The team enlisted the help of Kuno to develop a content marketing campaign that would support each of these initiatives. Kuno also worked closely with the IMARC team to develop the content.
For instance, one of the campaigns focused on promoting remote audits to review clinical research trial documents before these documents were submitted to the FDA. Conducting this type of audit in person can cost upward of $10,000 when you factor in the travel costs of sending several IMARC team members to the site to review documents. Doing this work remotely reduces these costs by as much as half.
To educate customers and prospects about the advantages and cost savings of an electronic trial master file audit, Kuno developed a campaign that included a video, infographic and checklist, as well as related blog posts and emails. Kuno optimized blog posts for search terms related to trial master file reviews, which brought new visitors to the IMARC website who were searching for best practices. More than 5,000 of IMARC’s existing contacts also interacted with these resources. One was a $50 million global neurovascular company that enlisted IMARC for several audits, including a trial master file audit.
